NIKI · NASDAQ
Niki BioSolutions (NIKI) Stock Price & Fundamentals
Niki BioSolutions (NIKI) closed at $610.46 on Oct 9, 2026, down 0.10% from the previous close of $611.07.
Share price, past year
1Y +15.16%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $610.46 |
| Sep 30, 2026 | $606.85 |
| Aug 31, 2026 | $583.06 |
| Jul 31, 2026 | $549.31 |
| Jun 30, 2026 | $581.24 |
| May 29, 2026 | $590.28 |
| Apr 30, 2026 | $599.88 |
| Mar 31, 2026 | $605.68 |
| Feb 27, 2026 | $582.63 |
| Jan 30, 2026 | $581.30 |
| Dec 31, 2025 | $601.40 |
| Nov 28, 2025 | $561.14 |
| Oct 31, 2025 | $528.26 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $527.11 – $626.55
Financials
Niki BioSolutions reported revenue of $431.38K for fiscal 2023, down 66.71% from fiscal 2022.
Niki BioSolutions reported a net loss of $1.36M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2023ended Dec 31, 2023 | $431.38K | −66.7% | −$2.82M | −654.8% | −$0.62 | −$7.73M |
| FY2022ended Dec 31, 2022 | $1.30M | −16.0% | −$9.80M | −756.2% | −$2.75 | −$12.51M |
| FY2021ended Dec 31, 2021 | $1.54M | — | −$25.05M | −1,624.6% | −$7.15 | −$14.78M |
Company profile
- Name
- Niki BioSolutions, Inc.
- Ticker
- NIKI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Measuring & Controlling Devices, NEC
- Headquarters
- 116 Village Boulevard, Suite 200, Princeton, NJ 08540
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001734005
Recent SEC filings
- Sep 14, 2026
- Sep 4, 2026
- Aug 21, 2026
- Aug 7, 2026
- Jul 20, 2026
Frequently asked questions
What is Niki BioSolutions's stock price?
Niki BioSolutions (NIKI) closed at $610.46 on Oct 9, 2026, down 0.10% from the previous close of $611.07.
How much revenue does Niki BioSolutions make?
Niki BioSolutions reported revenue of $431.38K for fiscal 2023, down 66.71% from fiscal 2022.
Sources and methodology
Fundamentals come from Niki BioSolutions, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures